News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Testing metabolites in blood predicts success of skin cancer treatment
Testing for a panel of metabolites in the blood can pick out which patients are likely to respond to a drug for skin cancer, new research reports.
The ICR pays tribute to researcher James Morden
The Institute of Cancer Research, London, has paid tribute to the life of James Morden, a senior medical statistician in the Clinical Trials and Statistics Unit (ICR-CTSU), who was tragically killed at the weekend.
New software can correct systematic 'batch effects' error in research data
Researchers have developed a new way to identify and correct for a type of systematic statistical error, known as 'batch effects', in large datasets.
ICR responds to Government’s policy paper on science and innovation after Brexit
The Institute of Cancer Research, London, has issued the following statement from Chief Executive Professor Paul Workman in response to a new policy paper by the Department for Exiting the European Union on the government's plans for science and innovation after Brexit.
New approach could better predict breast cancer risk due to family history
Scientists funded by Breast Cancer Now and Cancer Research UK have demonstrated a more accurate method to assess a woman’s familial risk of breast cancer, which could one day be added to existing models to help better predict an individual’s overall risk of breast cancer.
The ICR responds to Sir John Bell's Life Sciences Industrial Strategy
The Institute of Cancer Research, London, today responds to the publication of the Life Sciences Industrial Strategy. The ICR responded to the UK Government’s January 2017 green paper proposing how they intend to build a modern industrial strategy.
Bowel cancer study reveals impact of mutations on protein networks
For the first time, scientists have completed a detailed study of many of the proteins in bowel cancer cells.
Professor Johann de Bono to chair NCRI Cancer Conference
The ICR’s Professor Johann de Bono will take the prestigious position of Chair of the Scientific Committee for the 2017 National Cancer Research Institute (NCRI) annual conference in Liverpool this November.
Tributes for pioneering ICR radiotherapy scientist Dr Roy Bentley
Researchers at the Institute of Cancer Research, London, have paid tribute to their former colleague and radiotherapy pioneer Dr Roy Bentley, who sadly died last month.
Scientists uncover a deadly ‘addiction’ in oesophageal cancer
Scientists have discovered a new way of attacking oesophageal cancer cells that could make use of an existing drug in a new approach to treatment.
Patients with advanced cancer survive 10 years on first targeted cancer wonder drug
A significant minority of patients with advanced and aggressive cancer have survived more than 10 years after treatment with one of the first successful targeted cancer drugs.
Non-invasive imaging test could predict which kidney cancer patients will benefit from anti-vascular therapy
A magnetic resonance imaging test that measures the volume of blood in tumours could help select which patients will benefit from drugs that block blood vessel growth, a new study shows.
